Dulac Edward J III

Dulac Edward J III is listed in filings as EVP at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 6, 2026, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Jul 6, 2026. Reported amounts are shown as $84.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.